Recent advances may speed time to endometriosis diagnosis

Novel clinical recommendations, advanced diagnostic tools, research bring promise of relief sooner

The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery.

Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.

Endometriosis can develop when endometrial cells escape the uterus and cause lesions to form outside of it, leading to chronic pelvic inflammation. This can result in pain, infertility and decreased quality of life. The World Health Organization estimates that globally 190 million women of reproductive age — nearly 11% of all women — are affected by endometriosis.

Earlier this year, the American College of Obstetricians & Gynecologists (ACOG) released updated clinical guidance, including comprehensive recommendations for the diagnosis of endometriosis. The first-line recommendation replaces laparoscopy for obtaining a clinical diagnosis with “a symptom-based assessment, physical examination or both.” This recommendation is listed as strongly recommended but with low-quality evidence.

The goal of the new guidance is to speed diagnosis, so that endometriosis sufferers can more quickly access treatment and other resources. The guideline also highlights the need for further research into the pathogenesis and pathophysiology of endometriosis to facilitate the development of noninvasive methods that can accurately diagnose it without surgery.

At UC, Burns, a faculty member in the Division of Environmental Genetics and Molecular Toxicology in the Department of Environmental and Public Health Sciences, published work in 2018 showing in an animal model that it is an immune response that actually causes the endometrial lesions to begin. The lesions are driven by estrogen after the initial immune response.

In a follow-up study, Burns and colleagues used samples of menstrual effluent to study neutrophils (the white blood cells that initiate an immune response) in women with and without endometriosis.

Burns said the findings, published in 2025, “indicate that neutrophils are signaling incorrectly in endometriosis and may not be clearing debris as they should be doing." Morphological changes in white blood cells in menstrual effluent may be a noninvasive endometriosis diagnostic tool, she said.

Burns has a patent pending for a noninvasive endometriosis diagnostic tool.

Read the full Medscape article.

Featured image at top: Photo/iStock.

Related Stories

1

Driven by her own pain

March 8, 2026

Endometriosis is a painful and often debilitating disease that affects an estimated 6.5 million women in the U.S. It occurs when tissue similar to the lining of the uterus grows outside of it, causing pain, inflammation and sometimes infertility. Now a University of Cincinnati College of Medicine researcher is developing what is believed to be the first at-home diagnostic test.

2

Research findings may lead to new test for endometriosis

January 30, 2026

Endometriosis affects one in 10 women worldwide, and many go years before diagnosis. Symptoms include chronic pelvic pain, heavy bleeding during menstruation and/or sexual intercourse, bloating and fatigue. Katie Burns’ research at the University of Cincinnati is focused on creating a new, non-invasive test for endometriosis, using white blood cells as biomarkers. Burns, PhD, is an associate professor in the Department of Environmental and Public Health Sciences in the College of Medicine.

3

UC receives grant for AI use in medical education

February 26, 2026

The University of Cincinnati is turning to artificial intelligence to help solve a problem in medical training. The College of Medicine was awarded a grant valued at more than $1 million to use AI in advanced physician training through personalized learning.